Calamos Advisors LLC Has $14.94 Million Stock Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Calamos Advisors LLC decreased its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 0.2% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 49,776 shares of the company’s stock after selling 85 shares during the quarter. Calamos Advisors LLC’s holdings in HCA Healthcare were worth $14,940,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. Legacy Investment Solutions LLC bought a new position in HCA Healthcare during the third quarter worth about $39,000. Canoe Financial LP bought a new position in shares of HCA Healthcare during the third quarter worth $41,000. Capital Performance Advisors LLP acquired a new stake in HCA Healthcare during the 3rd quarter worth $41,000. Northwest Investment Counselors LLC acquired a new stake in shares of HCA Healthcare during the third quarter worth about $44,000. Finally, Pinnacle Bancorp Inc. increased its stake in HCA Healthcare by 50.0% during the 4th quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company’s stock worth $45,000 after purchasing an additional 50 shares in the last quarter. 62.73% of the stock is owned by institutional investors.

HCA Healthcare Stock Performance

NYSE:HCA opened at $334.65 on Tuesday. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $417.14. The company has a current ratio of 1.08, a quick ratio of 0.97 and a debt-to-equity ratio of 69.07. The stock has a market cap of $84.77 billion, a P/E ratio of 15.23, a PEG ratio of 1.13 and a beta of 1.64. The stock has a 50 day simple moving average of $313.33 and a 200 day simple moving average of $353.50.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $6.03 by $0.19. HCA Healthcare had a net margin of 8.16% and a return on equity of 586.47%. During the same period in the prior year, the company posted $5.90 earnings per share. Research analysts anticipate that HCA Healthcare, Inc. will post 24.89 earnings per share for the current year.

HCA Healthcare Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Monday, March 17th will be paid a dividend of $0.72 per share. This represents a $2.88 dividend on an annualized basis and a yield of 0.86%. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.66. The ex-dividend date of this dividend is Monday, March 17th. HCA Healthcare’s dividend payout ratio is presently 12.02%.

Insider Activity

In other news, SVP Phillip G. Billington sold 3,897 shares of the stock in a transaction dated Thursday, November 14th. The shares were sold at an average price of $350.00, for a total value of $1,363,950.00. Following the completion of the transaction, the senior vice president now owns 52,702 shares of the company’s stock, valued at approximately $18,445,700. This represents a 6.89 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Erol R. Akdamar sold 2,900 shares of the stock in a transaction that occurred on Thursday, November 14th. The shares were sold at an average price of $353.00, for a total transaction of $1,023,700.00. Following the completion of the transaction, the insider now directly owns 6,843 shares of the company’s stock, valued at approximately $2,415,579. The trade was a 29.76 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 1.70% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on the stock. Barclays dropped their price objective on shares of HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating on the stock in a report on Monday, January 27th. JPMorgan Chase & Co. reissued a “neutral” rating and issued a $380.00 target price on shares of HCA Healthcare in a research report on Tuesday, December 17th. Truist Financial cut their price objective on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. Wells Fargo & Company downgraded shares of HCA Healthcare from an “equal weight” rating to an “underweight” rating and reduced their price objective for the stock from $400.00 to $320.00 in a research note on Monday, November 25th. Finally, Raymond James cut HCA Healthcare from an “outperform” rating to a “market perform” rating in a research report on Friday, November 22nd. One analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have issued a buy rating and two have given a strong buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $385.67.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.